Rigel Pharma (RIGL) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $41.87 --0%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
